External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Simple SummaryNew assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might impro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CANCERS 2022-08, Vol.14 (15), p.3762
Hauptverfasser: Nauwelaers, Inne, Laudus, Nele, Peeters, Dieter, Acs, Balazs, Denkert, Carsten, Michiels, Stefan, Horlings, Hugo, Siziopikou, Kalliopi P., Ely, Scott, Zardavas, Dimitrios, Mustimbo, Roberts, Bartlett, John, Floris, Giuseppe, Hartman, Johan, van Deurzen, Carolien H. M., Ceusters, Dorien, Dequeker, Els, Salgado, Roberto
Format: Artikel
Sprache:eng
Schlagworte:
Artificial intelligence
Biomarkers
Breast cancer
Clinical medicine
Clinical trials
Conflicts of interest
Feedback
Health care
Immunotherapy
Laboratories
Lymphocytes
Participation
Pathology
Patients
Quality control
Quality management
Quality standards
Working groups
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Simple SummaryNew assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers14153762